Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Research & Development (2022 - 2026)

Scilex Holding (SCLX) posted Research & Development of $3.3 million for Q2 2026, up 3.93% on a QoQ basis from $3.2 million in Q1 2026, and down 46.08% year-over-year from $6.2 million in Q2 2025.

Analysis

Scilex Holding (SCLX) Research & Development (2022 - 2026) Analysis & Trends

Scilex Holding has reported Research & Development for 5 years, with the latest figure at $3.3 million in Q2 2026.

  • On a quarterly basis, Research & Development fell 46.08% year-over-year to $3.3 million in Q2 2026; TTM through Jun 2026 was $18.6 million, a 41.31% increase from a year earlier, with the FY2025 full-year figure at $20.7 million, up 114.81% from the prior year.
  • Research & Development was $3.3 million for Q2 2026 at Scilex Holding, up from $3.2 million in the prior quarter.
  • The five-year high for Research & Development was $8.2 million in Q4 2025, with the low at $1.2 million in Q3 2022.
  • Average Research & Development over 5 years is $3.3 million, with a median of $2.7 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Research & Development surged 274.68% in 2025, then sank 46.08% in 2026.
  • Over 5 years, Research & Development stood at $2.6 million in 2022, then increased by 5.28% to $2.7 million in 2023, then declined by 20.26% to $2.2 million in 2024, then soared by 274.68% to $8.2 million in 2025, then sank by 59.16% to $3.3 million in 2026.
  • The last three Research & Development figures came in at $3.3 million (Q2 2026), $3.2 million (Q1 2026), and $8.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 3.65 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 2.34 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -2.85 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 2.81 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -2.60 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 394.92 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 516.95 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 146.30 Mn
10 Scilex Holding 35.91 Mn -76.88 Mn 3.97 Mn 3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.34 Mn
Mar 31, 2026 3.21 Mn
Dec 31, 2025 8.17 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 6.19 Mn
Mar 31, 2025 2.46 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 2.35 Mn
Jun 30, 2024 2.00 Mn
Mar 31, 2024 3.11 Mn
Dec 31, 2023 2.73 Mn
Sep 30, 2023 4.07 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 2.74 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 1.24 Mn
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.63 Mn